DARZALEX 100 MG/5 ML INFUZYONLUK COZELTI
Condition : New
0
From UAE
To Germany
in 5-10 days
Description
DARZALEX (daratumumab) is a medication primarily used to treat multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. It belongs to a class of drugs known as monoclonal antibodies.
Mechanism of Action: DARZALEX works by targeting and binding to a protein called CD38, which is highly expressed on the surface of multiple myeloma cells. By binding to CD38, DARZALEX triggers a series of immune responses that lead to the destruction of myeloma cells, including antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and apoptosis.
Benefits: The benefits of DARZALEX include:
- Treatment of multiple myeloma in various settings, including newly diagnosed patients, relapsed or refractory disease, and as maintenance therapy.
- Improved response rates, progression-free survival, and overall survival in clinical trials when used alone or in combination with other medications.
- Reduction in symptoms associated with multiple myeloma, such as bone pain, anemia, and kidney dysfunction.
Related products
-
Uncategorized
Ivosidenib (Tibsovo): A Novel Treatment for Acute Myeloid Leukemia
Rated 0 out of 5Get Price